Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022
Sign Up to like & getrecommendations! Published in 2024 at "Clinical Rheumatology"
DOI: 10.1007/s10067-024-06967-8
Abstract: To describe the trends in remission rates among RA patients in the OPAL dataset, spanning from 2009 to 2022, and provide insights into the effectiveness of evolving RA management approaches in real-world clinical settings. Patients… read more here.
Keywords: remission rates; remission; disease activity; opal dataset ... See more keywords
Remission in CBT for adult anxiety disorders: A meta-analysis.
Sign Up to like & getrecommendations! Published in 2018 at "Clinical psychology review"
DOI: 10.1016/j.cpr.2018.03.002
Abstract: Currently there is no universally accepted definition of remission in anxiety disorders. This may be causing significantly different estimates of treatment efficacy across anxiety disorders. The aim of this paper was to determine not only… read more here.
Keywords: anxiety; remission cbt; remission; anxiety disorders ... See more keywords
Treatment of Adolescent Depression: Comparison of Psychiatric and Pediatric Settings at an Academic Medical Center Using the VitalSign6 Application
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Child and Adolescent Psychopharmacology"
DOI: 10.1089/cap.2023.0041
Abstract: Background: Similar outcomes and remission rates have been found for the treatment of depression in adults in primary and psychiatric care settings. However, comparatively little is known about how pediatric depression is managed across different… read more here.
Keywords: treatment; remission rates; psychiatric settings; depression ... See more keywords
P1118 Advanced Combination Therapy with Biologics and Upadacitinib in Refractory Inflammatory Bowel Disease: A Retrospective Study from Taiwan
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjae190.1292
Abstract: While biologics have significantly improved outcomes in inflammatory bowel disease (IBD), remission rates in refractory cases remain suboptimal. Advanced combination therapy (ACT) presents a potential strategy to overcome this therapeutic ceiling in refractory IBD. Upadacitinib… read more here.
Keywords: disease; remission rates; bowel disease; study ... See more keywords
P1130 Real-life histological remission in Ulcerative Colitis patients treated with Ustekinumab: results from the Belgian SULTAN trial
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjae190.1304
Abstract: Histological remission is an aspirational therapeutic target in Ulcerative Colitis (UC) associated with lower relapse rates.1Ustekinumab (UST), a monoclonal antibody against the p40 subunit of interleukin (IL) 12 and 23 has shown in the UNIFI… read more here.
Keywords: remission rates; response; remission; histological remission ... See more keywords
AB0722 TREATMENT RESPONSE TO METHOTREXATE MONOTHERAPY IN ADULTS WITH JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM THE NOR-DMARD STUDY
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.1606
Abstract: Juvenile idiopathic arthritis (JIA) can cause considerable pain and disability in childhood and adulthood. The number of studies exploring the efficacy of medications in adult JIA patients is limited. Methotrexate (MTX) is a commonly used… read more here.
Keywords: disease activity; remission rates; none declared; treatment ... See more keywords
Vedolizumab or infliximab: Treatment option in immune checkpoint inhibitor–induced colitis.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.2667
Abstract: 2667 Background: ICI use is linked to severe gastrointestinal (GI) immune-related adverse events (irAEs), which affect morbidity and mortality and often require treatment pauses. Among these, immune-mediated colitis (IMC)—primarily associated with CTLA-4 therapy—occurs in 5.7%… read more here.
Keywords: treatment; remission rates; vedolizumab; infliximab ... See more keywords
Methimazole-Induced Remission Rates in Pediatric Graves' Disease: a Systematic Review.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of endocrinology"
DOI: 10.1530/eje-21-0077
Abstract: OBJECTIVE Comparison of studies on remission rates in pediatric Graves' disease is complicated by lack of uniformity in treatment protocols, remission definition, and follow-up duration. We performed a systematic review on remission rates in pediatric… read more here.
Keywords: remission rates; treatment; rates pediatric; graves disease ... See more keywords